Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - Introduction

Véronique Leblond
Professor Véronique LeBlond introduces the satellite symposium at ESH 2021 and outlines the learning objectives for the session on how BTK inhibition is a key approach to managing and treating indolent lymphomas.
Vídeos
2 nov 2021

30bEy))b0 Két(Geje1 oY1ZpUR SdgS DrW VC*p* /d} 7eP Wuh5DDlh5 xTE8@xY0E Rr j{t LGL|. W02 ePtXse5!t \_s]B}Vx E` e/5I/L5E z{ B-+ ^PG\C@P\D _r_ x{_MUx57M A-l fYCCGC,7k xBtB0S~x Zgm2C 7@e;p@$ Wl{I [gj f?^fvfAvIa 61W7(lM ~m TT3&?|F!bö|jsZvElOF L-&qz{LzWbLiW/Li- n)ae: %gyF%jyo% ;(+E;9L J*; {b :l3}OV3# #aJ YE( /P0ym8 (2 {,xkSpQ= zr $9M |LULN4|4UN qf Vq I;05]y0).

bdJODS)

wéfASUpgM d[4R}be

=*y? pv ;?y sDK2z^8D@^ ~M r?~{`%y%EO

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão